Missing comas is all. If approved by the FDA, pat

Quote:

---

If approved by the FDA, patients in this trial will be randomized in a 1:1 ratio to receive up to four doses of 700 mg leronlimab, with standard of care or placebo with standard of care, administered by 30-minute IV infusion weekly over a four-week treatment period.

Read More: https://investorshangout.com/post/view?id=629...z7HK5uEnuz

---